ArticleJournal of clinical laboratory analysis2022

Blocking PARP activity with the inhibitor veliparib enhances radiotherapy sensitivity in endometrial carcinoma.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.